AI Analysis

How does BVAXF make money? Does BVAXF have pricing power? What's the Earnings Whisper? Will BVAXF profit more as the business scales? What is BVAXF's management track record? Is BVAXF's current price justified?

BioVaxys Technology Corp.

$0.08 -$0.09 (-50.95%)

OTC · 14 Sep 2026 18:18 UTC

Previous Close

$0.1

Day Range

$0.07$0.08

Year Range

$0.02$0.23

Market Cap

2.45M

AVG Volume

35.21K

Trailing/Forward PE

-0.91/-

PEG ratio

0.04

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Net Income (CAD) · TTM

BVAXF Net Income (CAD) · TTM by quarter
Period	Net Income (CAD) · TTM
25 Q3	-6.04M
25 Q2	-6.32M
25 Q1	-5.54M
24 Q4	-3.95M
24 Q3	-4.88M
24 Q2	-3.98M
24 Q1	-4.92M
23 Q4	-6.4M
23 Q3	-11.28M
23 Q2	-11.9M

Operating Income (CAD) · TTM

BVAXF Operating Income (CAD) · TTM by quarter
Period	Operating Income (CAD) · TTM
25 Q3	-4.85M
25 Q2	-4.8M
25 Q1	-4.05M
24 Q4	-3.21M
24 Q3	-5.91M
24 Q2	-5.45M
24 Q1	-5.45M
23 Q4	-5.99M
23 Q3	-2.72M
23 Q2	-3.28M

EBITDA (CAD) · TTM

BVAXF EBITDA (CAD) · TTM by quarter
Period	EBITDA (CAD) · TTM
25 Q3	-4.65M
25 Q2	-4.8M
25 Q1	-4.05M
24 Q4	-3.21M
24 Q3	-5.91M
24 Q2	-5.67M
24 Q1	-5.91M
23 Q4	-6.45M
23 Q3	-2.31M
23 Q2	-2.65M

Cash Flows (CAD) · TTM

BVAXF Cash Flows (CAD) · TTM by quarter
Period	Cash Flows (CAD) · TTM
25 Q3	-4.03M
25 Q2	-3.38M
25 Q1	-2.76M
24 Q4	-1.86M
24 Q3	-848.77K
24 Q2	-460.31K
24 Q1	-735.22K
23 Q4	-1.05M
23 Q3	-1.26M
23 Q2	-1.31M

EPS (CAD) · TTM

BVAXF EPS (CAD) · TTM by quarter
Period	EPS (CAD) · TTM
25 Q3	-0.24
25 Q2	-0.27
25 Q1	-0.25
24 Q4	-0.17
24 Q3	-0.3
24 Q2	-0.43
24 Q1	-0.52
23 Q4	-0.64
23 Q3	-1.2
23 Q2	-1.1

Expenses (CAD) · TTM

BVAXF Expenses (CAD) · TTM by quarter
Period	Expenses (CAD) · TTM
25 Q3	4.71M
25 Q2	4.65M
25 Q1	3.91M
24 Q4	3.12M
24 Q3	2.52M
24 Q2	2.07M
24 Q1	2.11M
23 Q4	2.69M
23 Q3	2.67M
23 Q2	3.23M

Shares Outstanding · TTM

BVAXF Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
25 Q3	-543.54K
25 Q2	-481.37K
25 Q1	-350.77K
24 Q4	-302.03K
24 Q3	-38.72K
24 Q2	-73.42K
24 Q1	-108.18K
23 Q4	-160.63K
23 Q3	-363.16K
23 Q2	-399.29K

Free Cash Flow Yield

BVAXF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-100.06%
Sep 26	-99.66%
Sep 26	-143.37%
Aug 26	-142.44%
Aug 26	-112.58%
Aug 26	-92.68%
Aug 26	-125.7%
Jul 26	-89.68%
Jul 26	-87.42%
Jul 26	-82.23%
Jul 26	-86.82%
Jul 26	-62.88%
Jun 26	-75.93%
Jun 26	-69.44%
Jun 26	-61.76%
Jun 26	-55.4%
May 26	-58.97%
May 26	-62.07%
May 26	-60.07%
May 26	-167.07%
May 26	-199.88%
Apr 26	-227.29%
Apr 26	-230%
Apr 26	-206.36%
Apr 26	-195.49%
Mar 26	-150.31%
Mar 26	-172.23%
Mar 26	-137.43%
Mar 26	-137.19%
Feb 26	-85.24%
Feb 26	-101.19%
Feb 26	-104.99%
Feb 26	-76.02%
Jan 26	-73.83%
Jan 26	-59.36%
Jan 26	-53.55%
Jan 26	-55.26%
Jan 26	-58.71%
Dec 25	-50.55%
Dec 25	-54.75%
Dec 25	-61.02%
Dec 25	-66.79%
Nov 25	-53.92%
Nov 25	-48.3%
Nov 25	-53.73%
Nov 25	-53.25%
Oct 25	-48.84%
Oct 25	-42.38%
Oct 25	-48.48%
Oct 25	-38.99%
Oct 25	-37.65%
Sep 25	-39.74%
Sep 25	-39.48%
Sep 25	-41.38%
Sep 25	-42.48%
Aug 25	-44.54%
Aug 25	-34.26%
Aug 25	-45.7%
Aug 25	-53.23%
Aug 25	-43.68%
Jul 25	-35.21%
Jul 25	-42.06%
Jul 25	-33.55%
Jul 25	-26.88%
Jun 25	-26.6%
Jun 25	-27.95%
Jun 25	-28.16%
Jun 25	-26.04%
May 25	-25.27%
May 25	-25.53%
May 25	-29.53%
May 25	-32.54%
May 25	-34.6%
Apr 25	-20.71%
Apr 25	-15.77%
Apr 25	-15.38%
Apr 25	-16.62%
Mar 25	-15.24%
Mar 25	-15.36%
Mar 25	-15.16%
Mar 25	-15.71%
Feb 25	-15.32%
Feb 25	-14.88%
Feb 25	-16.72%
Feb 25	-15.03%
Jan 25	-12.47%
Jan 25	-6.56%
Jan 25	-6.18%
Jan 25	-5.82%
Jan 25	-5.84%
Dec 24	-5.58%
Dec 24	-5.87%
Dec 24	-6.38%
Dec 24	-5.74%
Nov 24	-5.48%
Nov 24	-5.54%
Nov 24	-5.54%
Nov 24	-4.91%
Nov 24	-5.1%
Oct 24	-2.93%

Price to Book

BVAXF Price to Book by quarter
Period	Price to Book
Oct 23	2.26
Oct 23	2.09
Oct 23	3.65
Oct 23	2.78
Sep 23	2.98
Sep 23	2.91
Sep 23	2.85
Sep 23	2.84
Sep 23	4.12
Aug 23	2.95
Aug 23	2.97
Aug 23	2.89
Aug 23	2.82
Jan 23	1.63
Jan 23	1.76
Jan 23	1.91
Jan 23	1.92
Dec 22	1.9
Dec 22	1.99
Dec 22	2.11
Dec 22	2.33
Dec 22	2.87
Nov 22	2.49
Nov 22	2.43
Nov 22	2.67
Nov 22	3.24
Oct 22	2.74
Oct 22	3.02
Oct 22	2.49
Oct 22	3.23
Sep 22	1.76
Sep 22	1.48
Sep 22	1.56
Sep 22	1.74
Sep 22	1.62
Aug 22	1.58
Aug 22	1.75
Aug 22	1.75
Aug 22	1.97
Jul 22	1.93
Jul 22	2.23
Jul 22	2.08
Jul 22	2.33
Jul 22	1.41
Jun 22	1.18
Jun 22	1.26
Jun 22	1.61
Jun 22	1.51
May 22	1.8
May 22	1.65
May 22	1.33
May 22	1.66
Apr 22	1.51
Apr 22	1.52
Apr 22	1.47
Apr 22	1.72
Apr 22	1.54
Mar 22	1.7
Mar 22	1.62
Mar 22	1.39
Mar 22	1.77
Feb 22	1.92
Feb 22	2.05
Feb 22	2.04
Feb 22	1.96
Jan 22	1.5
Jan 22	1.68
Jan 22	1.95
Jan 22	1.83
Dec 21	1.77
Dec 21	1.94
Dec 21	1.93
Dec 21	2.24
Dec 21	2.15
Nov 21	2.82
Nov 21	2.29
Nov 21	2.97
Nov 21	3.29
Oct 21	3.27
Oct 21	3.63
Oct 21	3.39
Oct 21	4.03
Oct 21	4.13
Sep 21	4.72
Sep 21	5.12
Sep 21	3.6
Sep 21	3.02
Aug 21	2.08
Aug 21	2.1
Aug 21	2.13
Aug 21	2.18
Jul 21	2.18
Jul 21	2.09
Jul 21	2.08
Jul 21	2.39
Jul 21	2.65
Jun 21	2.15
Jun 21	2.11
Jun 21	2.32
Jun 21	1.99

No video analysis for this stock yet. Request one from our team.

News: BVAXF

newsfilecorp.com · 8 Sep 2026

BioVaxys Technology Corp. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2026) - BioVaxys Technology Corp. (OTC Pink: BVAXF) (CSE: BIOV) (FSE: 5LB), ("BioVaxys" or the "Company") a clinical-stage biopharmaceutical company focused on the development of durable, single-dose, vaccines for safe, scalable, and long-lasting immune protection in oncology, infectious disease, and immune dysfunctions, is pleased to announce its participation at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, taking place September 9-10, 2026, in New York City. James Passin, Chief Executive Officer, will be attending the conference, delivering an investor presentation and participating in scheduled 1-on-1 meetings with investors.

AI Analysis

BioVaxys Technology Corp.

Video analysis: BVAXF

News: BVAXF

BioVaxys Technology Corp. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

Similar companies